Huntington’s disease: Could a cancer drug hold the key?

Latest Posts

FDA Gives Pharmacists Thumbs Up for Paxlovid Prescribing

By Lizzy

Licensed pharmacists can now prescribe nirmatrelvir-ritonavir (Paxlovid) for COVID-19 patients at high risk of progressing to severe disease (though with some limitations), the FDA announced...

Comments closed

ASCO 2032: What Will Be the Big Story in Lung Cancer?

By Lizzy

New clinical research unveiled at the recent American Society of Clinical Oncology (ASCO) annual meeting has the potential to significantly alter the treatment of lung...

Comments closed

Promising New Depression Tx; Racially Skewed ADHD Dx; Effective Clozapine Monitoring

By Lizzy

The FDA gave ANeuroTech positive feedback during a pre-investigational new drug meeting on the phase IIIb clinical program testing their drug ANT-01 as adjunctive therapy...

Comments closed

T1D Stem Cell Trial Back On; Fifth Grade Obesity; Islet Autoantibodies Predictive

By Lizzy

After being hit with a clinical hold, Vertex Pharmaceuticals announced it's been given the FDA green-light to push forward on its phase I/II trial for...

Comments closed

Here’s How Many U.S. Deaths COVID Vaccines Prevented

By Lizzy

The U.S. COVID-19 vaccination program prevented millions of infections as well as hundreds of thousands of deaths, according to a modeling study. From December 2020...

Comments closed

A drug that is used to treat advanced skin lymphomas may also be effective in treating Huntington’s disease and other neurodegenerative diseases.

Source: MedicalNewsToday.com